Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer

Basit Öğe Kaydı
dc.authorid0000-0002-7451-7286en_US
dc.contributor.authorKefeli, Umut
dc.contributor.authorArslan, Çağatay
dc.contributor.authorYıldırım, Mahmut Emre
dc.contributor.authorIşıkdoğan, Abdurrahman
dc.contributor.authorKaradurmuş, Nuri
dc.contributor.authorKarabulut, Bülent
dc.date.accessioned2022-12-27T10:55:35Z
dc.date.available2022-12-27T10:55:35Z
dc.date.issued2021en_US
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyasyon Onkolojisi Ana Bilim Dalıen_US
dc.description.abstractBackground: Efficacy of anti-angiogenic and anti-EGFR agents has been demonstrated metastatic colorectal cancer (mCRC). Real-world evidence is especially important to detect the findings of patients outside of clinical trials.en_US
dc.identifier.citationKefeli, U., Arslan, Ç., Yıldırım, M.E., Işıkdoğan, A., Karadurmuş, N., Karabulut, B. (2021). Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer. Journal of Clinical Oncology, 39(15 Sup.(Meeting abstract e15561))en_US
dc.identifier.doi10.1200/JCO.2021.39.15_suppl.e15561
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15 (Sup. (Meeting abstract e15561))en_US
dc.identifier.urihttps://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.e15561
dc.identifier.urihttps://hdl.handle.net/11468/11143
dc.identifier.volume39en_US
dc.identifier.wosWOS:000708120301226
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.institutionauthorIşıkdoğan, Abdurrahman
dc.language.isoenen_US
dc.publisherLippincott William & Wilkinsen_US
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleReal-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal canceren_US
dc.titleReal-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer
dc.typeConference Objecten_US

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Dahili Tıp Bilimleri Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu